Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
3D MSCs in Acute Ischemic Stroke
NCT07635758Phase 2Recruiting
- Sponsor
- Chinese PLA General Hospital
- Start
- Jun 2026
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
A Phase 2 trial of human placenta-derived 3d mesenchymal stem cells in ischemic stroke, sponsored by Chinese PLA General Hospital. Started Jun 2026; status: recruiting.
02
Drugs
human placenta-derived 3d mesenchymal stem cells
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07635758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07635758.